Research, Portfolio Monitoring, Investment Tools, and More.

Name: MarketBeat All Access
Brand: MarketBeat
Price: 249.00 USD
Availability: InStock

You've subscribed to our free daily email newsletter. Now take your investing game to the next level with MarketBeat All Access -- MarketBeat All Access is the premier all-in-one stock research solution that helps you identify the best stocks, monitor your portfolio, and keep track of the market. You get our top stock ideas, best-in-class research tools, real-time alerts, proprietary research reports, and much more.

Start Your Free Trial Today

Free For 30 Days. Then, $249.00/year.

a couple facing laptop and staring at it

Get the Ultimate Investment Research Toolkit with MarketBeat All Access

Whether you are a professional trader or an every-day investor, these tools will help you become a more confident and profitable investor:

Top-Rated Stocks

Discover stocks with our top-rated stock lists, showcasing top recommendations from Wall Street's best-performing and most accurate research analysts.

Trending Stocks

Our trending stock tools monitor social media chatter and news sentiment in real-time to help identify hot stocks before you hear about them on the news.

The Idea Engine™

Powered by the latest artificial intelligence models, algorithmic factors, technical indicators, new Idea Engine™ stock ideas are released at the start of each week.

Proprietary Reports

Stay ahead of the curve with exclusive research reports about emerging industries and market trends, crafted by our expert analysts and reserved solely for All Access subscribers.

Stocks to Short

Pinpoint stocks recently affected by negative news or technical indicators - a helpful starting point for investors to identify potential risks or opportunities.

Portfolio Monitoring

All Access offers comprehensive portfolio monitoring and highly customizable real-time alerts, ensuring you stay informed about your stocks' performance and breaking news via email or SMS.

More All Access Benefits

Start Your 30-Day Free Trial

Top Stock Ideas Your Ultimate Investment Research Toolkit

No matter what your investment strategy, MarketBeat All Access will help you find companies with the ingredients to outperform the market. Your subscription includes a suite of screeners and tools that help you easily search and identify stocks that align with your investment strategy.

6 Stock Screeners
75+ Technical Filters
12+ Industry Reports
15+ Exclusive Stock Lists
Unlimited Stocks in Your Watchlist

Start Your 30-Day Free Trial

Your Success is Our Success Take The Guesswork out of Investing

We believe that successful investing shouldn't be complicated, which is why MarketBeat All Access simplifies stock selection for our members by regularly providing new ideas and insights.

As a subscriber, you'll immediately receive our top stock ideas enabling you to spend less time navigating the complexities of the market and more time doing what you love.

Start Your 30-Day Free Trial

MarketBeat All Access on desktop and phone devices

Stock Ideas from The Idea Engine™

NIO NIO

down 3.88% 90 days after 3/11/2026

The MarketBeat Idea Engine™ identified NIO as having momentum on 3/11/2026. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $5.68 at the time of the recommendation. After 90 days, the stock was trading at $5.46, representing a -3.88% ROI. The current price for NIO is $5.30.

ALG Alamo Group

down 11.54% 90 days after 3/9/2026

The MarketBeat Idea Engine™ identified Alamo Group as having a strong negative sentiment on 3/9/2026. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $168.34 at the time of the recommendation. After 90 days, the stock was trading at $148.91, representing a -11.54% ROI. The current price for ALG is $153.04.

AMPX Amprius Technologies

up 20.09% 90 days after 3/9/2026

The MarketBeat Idea Engine™ identified Amprius Technologies as having a strong positive sentiment on 3/9/2026. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $16.37 at the time of the recommendation. After 90 days, the stock was trading at $19.66, representing a 20.09% ROI. The current price for AMPX is $17.41.

GENI Genius Sports

up 9.86% 90 days after 3/9/2026

The MarketBeat Idea Engine™ identified Genius Sports as having a strong negative sentiment on 3/9/2026. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $5.38 at the time of the recommendation. After 90 days, the stock was trading at $5.91, representing a 9.86% ROI. The current price for GENI is $6.75.

GO Grocery Outlet

up 30.29% 90 days after 3/9/2026

The MarketBeat Idea Engine™ identified Grocery Outlet as having a strong negative sentiment on 3/9/2026. An alert was sent out to MarketBeat subscribers at approximately 9:00 AM EST. The stock was trading at $6.57 at the time of the recommendation. After 90 days, the stock was trading at $8.56, representing a 30.29% ROI. The current price for GO is $8.87.

Trusted By Many All Access Empowers Individual Investors

"I'm not kidding — I made my money back for the initial MarketBeat subscription in about 11 minutes."

– Barry S. from Lanesborough, Massachusetts

(Barry's results are not typical. Your experience with MarketBeat All Access may vary.)

"I’m on the MarketBeat website every day. I regularly read the reports and use all the screeners."

– John M. from Atlanta, Georgia

(John's results are not typical. Your experience with MarketBeat All Access may vary.)

"MarketBeat gives me the data and confidence to stay in control of my investing."

– Matt K. from Lenexa, Kansas

(Matt's results are not typical. Your experience with MarketBeat All Access may vary.)

"I’m not going to pay $50,000 a year for an institutional tool when MarketBeat gives me what I need."

– David from San Diego, California

(David's results are not typical. Your experience with MarketBeat All Access may vary.)

"I like hearing different perspectives on the market—MarketBeat helps me do that."

– Das C. from San Diego, California

(Das' results are not typical. Your experience with MarketBeat All Access may vary.)

Very worthwhileMarketBeat is a valuable plethora of up-to-date market information from earnings reports to politician's stock buys and sell. Daily stock reports keep you informed on the market and stocks you are interested in. It also provides up to minute information on your portfolio and a weekly stock pick to examine. Very worthwhile.

— Gary K.
10/2/2025

My #1 go to sourceMy #1 go to source for a quick summary of my portfolio, with trend lines, daily analysis and articles on many of my holdings.

— Bill G.
9/30/2025

Excellent daily perspective on the marketsIn my experience, MarketBeat has proved to be an excellent value. The information is timely concise and well presented. I enjoy reading the well informed guest editorials. MarketBeat gives me an excellent daily perspective on the markets.

— Gary W.
9/30/2025

So informative and well doneI love to get the analysts' on stocks from MarketBeat - which stocks' rating went up, or were downgraded or when new coverage was initiated. This has helped me not only monitor stocks in my current portfolio, but open my eyes to other stocks that I hadn't considered or was not even aware of. There are also many great articles that come to my inbox from MarketBeat on the status of stocks or comparison of stocks or hot stocks in a sector or whatever it may be. They are so informative and well done.

— Vivian L.
9/29/2025

MarketBeat All Access is used by enthusiastic beginners and professional traders from these firms and more:

11,730

All Access Subscribers

3,339,533

Community Members

81,492,384

Traders Per Year

Free Trial Offer You are only one step away from gaining access to world-class investing tools and research.

Get Your 30-Day Free Trial of MarketBeat All Access Today!

Annual Billing

$249.00/year

Save $99.00 with annual billing!

Monthly Billing

$29.00/month

Experience MarketBeat All Access Risk-Free with Our 30-Day Free Trial

We're confident you'll discover the immense value of MarketBeat All Access during your free 30-day trial that we offer it with no strings attached. If you decide to cancel within the first 30 days, you can do so online with no questions asked.

Try it out – you have nothing to lose.

Start Your 30-Day Free Trial

MarketBeat Plans: Free vs. All Access Full Feature Comparison

Feature	Daily Ratings Free	All Access $249/yr or $29/mo

Daily Financial News
Top News Headlines
Premium Articles
Weekly Market Preview Delivered every Sunday, MarketBeat's weekly market preview provides an executive briefing on the most important market events and stories that will be in the news in the coming week.
Real-Time News Feed
Newsletter Delivery Time	1:30 PM ET	8:50 AM ET & 4:30 PM ET
Market Data
Analysts' Upgrades and Downgrades
Congressional Trading
Dividend Announcements
Earnings Calls and Results
FDA Calendar
Insider Buying and Selling
Institutional Buying and Selling
Portfolio Monitoring
My MarketBeat Portfolio Monitoring Tool
My MarketBeat Watchlist Size	Up to 10 stocks	Unlimited
Personalized News for Your Stocks Receive a personalized A.I. generated summary of the news and market events that are most likely to impact your stock portfolio.	Up to 10 stocks	Unlimited
Email & SMS News Alerts Receive an email or SMS alert whenever one of your stocks receives a ratings change, announces a dividend, announces earnings, has insider trading activity or has other important news.	Up to 10 stocks
Follow Analysts
Follow Brokerages
Brokerage Linking Create a watchlist securely linked to your brokerage account for automatic updates whenever you buy or sell stock.

Stock Screeners
Stock Screener
Dividend Screener
Earnings Screener
ETF Screener
Insider Trades Screener
Ratings Screener
Premium Filters (news sentiment, MarketRank, consensus) Filter stocks on screener pages by news sentiment, MarketRank, and Wall Street analysts' consensus.
Web-Based Research Tools
Calculators
Compare Stocks
Idea Engine™
Momentum Alerts
Excel/CSV Data Export Export up to 6 months of analyst recommendations, dividend announcements, earnings announcements and insider trades for your own analysis.
Trending Stocks
Trending Stocks on MarketBeat
Media Sentiment Stocks
Media Sentiment Analysis See which stocks are receiving the most positive news coverage right now.
Company Profile Pages
Analyst Recommendations View all recommendations issued for a stock in the last two years.
Consensus Ratings and Targets View current consensus analyst recommendations and price targets for any stock.
Dividend History View the most recent five years of dividend payments and key metrics dividend investors use to rate dividend-paying stocks.
Earnings History and Estimates View historical earnings information and earnings estimates for upcoming quarters.
FDA Events Track FDA approvals, PDUFA dates, clinical trial outcomes, and other regulatory milestones for biotech and pharmaceutical companies, with a visual timeline of past and upcoming events for each drug.
Insider Trading History View the most recent five years of insider trading activity and recent institutional buying and selling activity for any stock.
Key Financial Metrics View key financial metrics and technical indicators for any stock.
News and Social Media Feed View real-time news stories and social media postings from StockTwits for any publicly traded company.
Stock Charts View a real-time stock chart for any publicly traded company.

Proprietary Research Reports
Top Insider Buying
Top Insider Selling
Brokerage Performance Rankings
Analyst Performance Rankings
Top-Ranked Stocks
Lowest-Ranked Stocks
Most Upgraded
Most Downgraded
Trader's Guide to Equities Research
Stock Picks from Top-Rated Analysts View recent "buy" and "strong buy" ratings from our top-ranked research firms.
Monthly Premium Reports
Subscription Benefits
Priority Newsletter Delivery
Premium Customer Support
Ad-Free Browsing on MarketBeat.com
Get Started	Sign Up	Start Your 30-Day Free Trial

Frequently Asked Questions About MarketBeat All Access

MarketBeat All Access is $249 per year with annual billing or $29 per month with monthly billing. Annual billing saves $99 compared to paying monthly. Every new subscription includes a 30-day free trial or a 30-day money-back guarantee.

Yes. MarketBeat offers a free tier that includes the Daily Ratings newsletter, a watchlist of up to 10 stocks, the stock comparison tool, analyst upgrades and downgrades, and top news headlines.

A paid plan, MarketBeat All Access, adds unlimited watchlists, stock screeners, real-time alerts, premium research reports, the Idea Engine, analyst and brokerage following, and priority newsletter delivery.

MarketBeat's free plan covers the essentials: a daily newsletter, a 10-stock watchlist, basic research tools, and top headlines.

MarketBeat All Access expands on those tools with unlimited watchlists, six stock and ETF screeners with 75+ technical filters, real-time email and SMS alerts, exclusive research reports, the Idea Engine, earnings call transcripts, and priority newsletter delivery at 8:50 AM and 4:30 PM ET.

See the full feature comparison here.

MarketBeat All Access is built for investors who want to save time finding research, track more than 10 stocks, and receive faster access to market-moving information through real-time alerts and premium research tools. Subscribers use it to monitor analyst ratings changes, earnings activity, dividend announcements, insider and institutional trading trends, and stock-specific news from a single platform.

Every new subscription includes a 30-day free trial or a 30-day money-back guarantee, so you can test whether it fits your investing workflow before committing. Thousands of investors currently subscribe to this premium subscription.

MarketBeat is a financial media company founded in 2011 and headquartered in Sioux Falls, South Dakota. MarketBeat is accredited by the Better Business Bureau (BBB), independently verified by SafeSiteCertified and PrivacyVerified, and has been featured in Barron's, the Wall Street Journal, CNBC, MarketWatch, and Seeking Alpha. Millions of investors read MarketBeat's daily newsletters.

New subscribers get 30 days of full MarketBeat All Access for free. A payment method is required to start the trial, but you can cancel anytime within the 30 days online with no questions asked — you won't be charged.

After 30 days, your chosen plan (annual at $249/year or monthly at $29/month) begins automatically unless you cancel first. Free trials are limited to one per customer every 12 months.

The 30-day money-back guarantee applies to subscribers who skip the trial and subscribe directly.

Yes. You can cancel MarketBeat All Access online anytime through your account. Canceling stops future billing immediately; you'll keep access until the end of your current paid period. Every new subscription includes either a 30-day free trial or a 30-day money-back guarantee, so you can cancel during the trial without being charged, or request a full refund within the first 30 days of a direct subscription — no questions asked.

MarketBeat All Access includes unlimited stock watchlists, real-time email and SMS alerts, six stock and ETF screeners with 75+ technical filters, 15+ exclusive stock lists, 12+ industry reports, the Idea Engine for weekly stock ideas, monthly premium research reports (10–20 pages each), media sentiment analysis, Excel/CSV data export, priority newsletter delivery at 8:50 AM and 4:30 PM ET, and ad-free browsing. The full feature list is in the comparison above.

The Idea Engine™ is a MarketBeat All Access feature that uses AI models, algorithmic factors, and technical indicators to identify stocks showing near-term momentum, sentiment shifts, or other notable trading signals. New Idea Engine picks are released at the start of each week and delivered via email and SMS alerts to All Access subscribers.

MarketBeat All Access is designed for retail investors who want deeper market research, real-time alerts, and access to institutional-quality market data in one place. Subscribers use it to follow analyst ratings, insider and institutional trading activity, earnings calls, dividend announcements, and stock-specific news from a single dashboard.

It's well-suited for long-term investors, dividend-focused investors, and active stock-pickers following more than 10 positions. MarketBeat is not a brokerage and does not execute trades; most subscribers pair it with their existing brokerage account.

MarketBeat specializes in aggregating institutional-grade data — analyst ratings from hundreds of brokerage firms, insider Form 4 filings, 13F institutional holdings, earnings calls, and dividend announcements — and making it searchable and filterable for individual investors. MarketBeat provides data and research tools rather than specific buy/sell recommendations, and focuses on depth in U.S., Canadian, and U.K. markets. The proprietary MarketRank™ score combines analyst opinion, short interest, dividend strength, news and social media sentiment, institutional ownership, and earnings and valuation into a single score for each covered stock.

MarketBeat covers thousands of publicly traded companies listed on major exchanges in the United States (NYSE, NASDAQ, OTCMKTS), Canada (TSX), and the United Kingdom (LSE). Coverage includes common stocks, ETFs, ADRs, and dividend-paying securities.

MarketBeat All Access integrates with most major U.S. brokerages through Plaid, the secure financial-data service used across fintech platforms. Once linked, your holdings are automatically imported into your MarketBeat watchlist and kept in sync. Supported brokerages include Charles Schwab, Vanguard, E*TRADE, Robinhood, Interactive Brokers, and most other major firms. MarketBeat does not execute trades — you continue to buy and sell through your brokerage directly.

Yes. MarketBeat All Access subscribers can follow individual Wall Street analysts or specific brokerage firms and receive email and SMS alerts whenever they take action — including new coverage initiations, ratings upgrades, ratings downgrades, price target changes, and coverage terminations. This lets investors track the analysts and firms whose research they trust most, without needing to monitor multiple platforms. MarketBeat aggregates ratings from hundreds of brokerages and tracks the historical accuracy of analysts in its database, so users can identify and follow top-rated analysts based on past performance.

Start Your 30-Day Free Trial

Research, Portfolio Monitoring, Investment Tools, and More.